Showing results (11-20 of 48) with videos related to

Sort By:
Pageof 5
Current Neuropharmacology|February 7, 2018
<i>In Vitro</i> Metabolite Profiling of ADB-FUBINACA, A New Synthetic CannabinoidJeremy Carlier, Xingxing Diao, Ariane Wohlfarth, et al.
Current Neuropharmacology|November 11, 2016
In Vitro Metabolite Profiling of ADB-FUBINACA, A New Synthetic CannabinoidJeremy Carlier, Xingxing Diao, Ariane Wohlfarth, et al.
Rapid Communications in Mass Spectrometry : RCM|March 23, 2016
Metabolic profiling of new synthetic cannabinoids AMB and 5F-AMB by human hepatocyte and liver microsome incubations and high-resolution mass spectrometryMaria Andersson, Xingxing Diao, Ariane Wohlfarth, et al.
Clinical Toxicology (Philadelphia, Pa.)|December 23, 2015
Prolonged hypoglycemia after a suicidal ingestion of repaglinide with unexpected slow plasma eliminationRoland Elling, Marco Simon Spehl, Ariane Wohlfarth, et al.
Analytical Chemistry|March 6, 2013
Qualitative confirmation of 9 synthetic cannabinoids and 20 metabolites in human urine using LC-MS/MS and library searchAriane Wohlfarth, Karl B Scheidweiler, Xiaohong Chen, et al.
The AAPS Journal|January 27, 2016
In Vitro and In Vivo Human Metabolism of Synthetic Cannabinoids FDU-PB-22 and FUB-PB-22Xingxing Diao, Karl B Scheidweiler, Ariane Wohlfarth, et al.
Forensic Science International|July 27, 2010
Urine tested positive for ethyl glucuronide and ethyl sulfate after the consumption of yeast and sugarAnnette Thierauf, Ariane Wohlfarth, Volker Auwärter, et al.
Pageof 5